3 locations, the requirement of a TTTV PAM may limit the availability of suitable target sites, reducing the practical utility of Cpf1. To address this limitation, we aimed to engineer variants of Cpf1 that can recognize alternative PAM sequences in order to increase its targeting range.
Previous work has shown that the PAM preference of Cas9 can be altered by mutations to residues in close proximity with the PAM DNA duplex [6] [7] [8] [9] . We sought to investigate whether the PAM preference of Cpf1, despite its strong evolutionary conservation 1 , can also be modified. Based on the crystal structure of AsCpf1 in complex with crRNA and target DNA 10 , we selected 64 residues in AsCpf1 in proximity to the PAM duplex ( Fig. 1a) for targeted mutagenesis. By randomizing the codons at each position using cassette mutagenesis 11 , we constructed a plasmid library of AsCpf1 variants encoding all possible single amino acid substitutions at these residues. To assay cleavage activity, we adapted a plasmid interference-based depletion screen in E. coli 1, 6, 12, 13 to identify variants within this library with cleavage activity at non-canonical PAMs (Fig. 1b) . In our modified assay, a pool of E. coli, each expressing crRNA and a variant of Cpf1, was transformed with a plasmid carrying an ampicillin resistance gene and a target site bearing a mutated PAM.
Cleavage of the target resulted in the loss of ampicillin resistance and subsequent cell death when grown on ampicillin selective media. By sequencing the plasmid DNA in surviving bacteria, we identified the variants that were depleted; these variants were active at the mutant PAM.
In order to use this assay to distinguish the variants from WT AsCpf1, we first evaluated the sensitivity of WT AsCpf1 to substitution mutations in the PAM, as determined by plasmid depletion in E. coli due to successful plasmid interference. We focused on PAMs with single nucleotide substitutions (i.e., NTTV, TNTV, and TTNV, where V was arbitrarily chosen to be C).
When transformed with NTTC and TCTC PAMs, E. coli expressing WT AsCpf1 had negligible survival ( Fig. 1c) , indicating that these PAM sequences supported AsCpf1-mediated DNA plasmid cleavage and were not usable for screening the variant library. In contrast, the other five PAMs with a single mutation (TATC, TGTC, TTAC, TTCC, and TTGC) had notable survival rates. We subsequently screened the variant library for activity at these five PAMs, as well as an additional PAM with a double mutation (TCCC) ( Fig. 1d and Supplementary Fig. 1a ).
Following sequencing readout, approximately 90% of the variants in the library were present in enough abundance in the negative control (minimum ~15 reads) to assess depletion. For TATC, TGTC, TTCC, and TCCC PAMs, at least one AsCpf1 variant in the library was highly depleted (≥15-fold) ( Fig. 1d) . For TATC and TGTC, the majority of depleted hits were amino acid substitutions at K548, a conserved residue that forms hydrogen bonds with the second base of the PAM 10, 14 . A smaller number of hits were observed for TTCC and TCCC, most notably an arginine substitution at S542, a non-conserved residue.
We evaluated whether hits identified in the screen had activity in HEK293FT cells ( Fig. 2a and   2b) . Most of the hits tested generated indels for their corresponding PAMs; in particular, K548V was most active at a TATC genomic target site, while S542R dramatically increased activity for both a TTCC and a TCCC target site. Combining the top single amino acid mutations into double and triple mutants further improved activity ( Fig. 2b and Supplementary Fig. 1b ). We selected the variants with the highest activity, S542R/K607R (hereafter referred to as RR) and S542R/K548V/N552R (hereafter referred to as RVR), for further investigation.
To assess the global PAM preference of the RR and RVR variants and to compare with the WT, we adapted an in vitro PAM identification assay described previously ( Fig. 2c) 1, 15 . We incubated cell lysate from HEK293 cells expressing AsCpf1 (or a variant) with in vitro-transcribed crRNA and a library of plasmid DNA containing a constant target preceded by a degenerate sequence (5'-NNNNNNNN-target). For each Cpf1 variant, ten replicates of the cleavage reaction were carried out, each incubated for a different amount of time, in order to determine cleavage kinetics (see Methods). As expected, WT AsCpf1 was most active at TTTV PAMs ( Fig. 2d) , although we also observed cleavage at low rates for NTTV, TCTV, TTCV, and TTTT, consistent with our observations in HEK293 cells ( Supplementary Fig. 1c ). In contrast, the RR and RVR variants had the highest activity at TYCV/CCCC and TATV PAMs, respectively, compared to little or no activity for WT at those PAMs ( Fig. 2d) . Collectively, these new PAMs increase the targeting range of Cpf1 by 2.6-fold in non-repetitive regions of the human genome ( Fig. 2e ) and reduce the sizes of genomic DNA stretches that cannot be targeted ( Fig. 2f ).
Next, we investigated the activity of the RR and RVR variants at their preferred PAMs across a larger panel of target sites in HEK293 cells ( Fig. 2g and 2h ). Both variants mediated robust editing across the four genes assessed (CFTR, DNMT1, EMX1, and VEGFA); in particular, 14/16 (88%) of TYCV target sites had >20% indel for RR (vs. 3/16 for WT), and 10/13 (77%) of TATV target sites had >20% indel for RVR (vs. 0/13 for WT). Moreover, the RR variant also had significant activity at VYCV target sites (>20% indel for 25/37 (68%) of sites) ( Fig. 2h ), although this activity was somewhat lower than at TYCV sites, consistent with the in vitro cleavage assay. We also tested the RR variant in murine Neuro2a cells (Supplementary Fig. 1d ) and observed high rates of editing (>20% indel for 7/9 TYCV or CCCC sites).
We evaluated the genome-wide editing specificity of the RR and RVR variants using BLISS (double-strand breaks labeling in situ and sequencing), which quantifies DNA double-stranded breaks (DSBs) across the genome 16 . To compare the variants to WT, we restricted our analysis to target sites bearing PAMs that can be reliably cleaved by all three enzymes; TTTV was the only PAM that met this criterion, although it has lower activity for the RR variant. For three of the four target sites evaluated (VEGFA, GRIN2B, and DNMT1), no off-target activity was detected from deep sequencing of any of the BLISS-identified loci ( Fig. 3a) , either for WT or for the variants.
For the fourth target site (EMX1), BLISS identified 6 off-target sites with detectable indels; all 6 sites had a TTCA PAM and no more than one mismatch in the first 19 bp of the guide. As expected, both variants had increased activity at these off-target sites compared to WT, consistent with their increased ability to recognize TTCA PAMs. On the other hand, when targeting a different site with known TTTV off-target sites 5 , the variants exhibited reduced off-target activity (Fig. 3b) , which is also consistent with PAM preference. Collectively, these results indicate that the variants retain a high level of editing specificity that is comparable to WT AsCpf1.
Finally, we investigated whether specificity can be improved by removing non-specific contacts between positively-charged or polar residues and the target DNA, similar to strategies previously employed with Streptococcus pyogenes Cas9 (SpCas9) 17, 18 . We identified K949A, which is located in the cleft of the protein that is hypothesized to interact with the non-target DNA strand, as a candidate (Supplementary Fig. 1e ). When combined with the RR and RVR variants, K949A 6 reduced cleavage at all off-target sites assessed ( Fig. 3c) while maintaining high levels of on-target activity ( Fig. 3d ).
All mutations we identified are sufficiently close to the PAM duplex to introduce new or altered interactions with the DNA, consistent with previous work to change the PAM recognition of Cas9 6, 7 . Based on the crystal structure, we hypothesize that S542R, which is present in both the RR and RVR variants, may function by creating new electrostatic or hydrogen bonding interactions with DNA bases through its positively-charged arginine side chain ( Supplementary Fig. 1f ). These interactions may resemble the T1337R mutation in SpCas9, which creates two new hydrogen bonds with a 4 th guanine base in the PAM 8, 9 . It is unclear how the other mutations contribute to alteration of PAM preference in the Cpf1 variants. Further structural studies will elucidate their altered PAM recognition mechanisms.
Because Cpf1-family enzymes have strong sequence and structural homology, the S542, K548, N552, and K607 positions in AsCpf1 have unambiguous correspondences in other Cpf1 orthologs.
This raises an intriguing question of whether the mutations we identified can be applied to alter the PAM preferences of other orthologs. For instance, we hypothesize that, based on the crystal structure 19 , LbCpf1 can be engineered to recognize TYCV/CCCC and TATV PAMs by the mutations G532R/K595R and G532R/K538V/Y542R, respectively.
In summary, we have demonstrated that despite strong evolutionary conservation, the PAM preference of Cpf1 can be altered by suitable mutations to residues close to the PAM duplex. The two variants of AsCpf1 we engineered can robustly cleave target sites with TYCV/CCCC and TATV PAMs, respectively, in mammalian cells. Collectively, they extend the targeting range of Cpf1 to one cleavage site for every 8.7 bp in non-repetitive regions of the human genome, which compares favorably to SpCas9. We anticipate that these variants will be a useful addition to the CRISPR-Cas genome engineering toolbox.
Methods
Library construction. Human codon-optimized AsCpf1 driven by a T7 promoter was cloned into a modified pACYC backbone, and unique restriction sites were introduced flanking the selected PAM-proximal AsCpf1 residues via suitable silent mutations. For each residue, a mutagenic insert was synthesized as short complementary oligonucleotides (Integrated DNA Technologies), with the mutated codon replaced by a degenerate NNK mixture of bases (where K = G or T). Each degenerate codon position was also barcoded by creating a unique combination of silent mutations in non-mutated neighboring codons in order to correct for sequencing errors during screen readout.
The variant library was assembled by cassette mutagenesis, mini-prepped, pooled, and precipitated with isopropanol. Indel quantification. All indel rates were quantified by targeted deep sequencing (Illumina). For indel library preparation, cells were harvested approximately 3 days after transfection, and genomic DNA was extracted using a QuickExtract DNA extraction kit (Epicentre) by resuspending pelleted cells in QuickExtract (80µL per 24-well, or 20µL per 96-well), followed by incubation at 65°C for 15min, 68°C for 15min and 98°C for 10min. PCR amplicons for deep sequencing were generated using two rounds of PCR as previously described 20 . Indels were counted computationally by searching each amplicon for exact matches with strings delineating the ends of a 70bp window around the cut site. The distance in bp between these strings was then compared to the corresponding distance in the reference genome, and the amplicon was counted as an indel if the two distances differed. For each sample, the indel rate was determined as (number of reads with an indel) / (number of total reads). Samples with fewer than 1000 total reads were not included in subsequent analyses. Where negative control data is not shown, indel percentages from targeted deep sequencing represent background-subtracted maximum likelihood estimates.
In particular, for a sample with R total reads, of which n ≤ R are indels, and false positive rate 0 ≤ α ≤ 1 (as determined by the negative control), the true indel rate was estimated as max 0, [(7/9) − <]/(1 − <) . 
BLISS.
All BLISS experiments and analysis were performed as previously described 16 .
Sample size and statistics. The sample sizes for each measurement were n = 3 for bacterial colony counts (Fig. 1c) ; n = 4 combinatorial mutagenesis (Fig. 2b) and for indel analysis of BLISS loci (Fig. 3a) ; and n = 2 or n = 3 for all other indel data. The error bars in all figures show standard error of the mean. DNMT1  CFTR  EMX1  VEGFA   GTCG  ACCA  ACCA  ATCC  ATCC  ATCA  GTCC  CCCG  ATCG  ATCG  CCCA  CTCG  GTCC  GCCG  GCCC  CCCG  GCCA  CTCG  GTCA  CTCC  GCCC  ACCA  ACCC  CCCA  GCCG  GCCC  ACCC  GCCA  GTCC  GTCA  GCCG  CTCG  CCCG  CTCC  ATCC TATC   TATA   TATC   TATA  TATG  TATA  TATC  TATG  TATA  TATG  TATG  TATC  TATA  TATC  TATA  TATG   0 
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